With 19 years of innovative research and development, TABP focuses on transcription factors development and therapeutic cell products. The establishment of technology platform enables rapid cell proliferation, which has completed the pre-clinical studies and is on its way to investigational new drug application.
Based on the fundamental research and innovative development, TABP aims to become a competitive biotechnology provider nationwide.